IL10 and hepatocellular carcinoma: For a subgroup of non-Asian population, there was a significant association between the IL-10 (-1082 A/G) and hepatocellular carcinoma in protection using the heterozygous model (OR: 0.60, 95% CI: 0.43–0.85, I2 = 30.3%, fixed effect model, four studies).